BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Courcoul A, Brinster A, Decullier E, Larbre JP, Piperno M, Pradat E, Tebib JG, Wendling D, Coury F. A bicentre retrospective study of features and outcomes of patients with reactive arthritis. Joint Bone Spine 2018;85:201-5. [PMID: 28238883 DOI: 10.1016/j.jbspin.2017.01.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Bekaryssova D, Yessirkepov M, Zimba O, Gasparyan AY, Ahmed S. Reactive arthritis before and after the onset of the COVID-19 pandemic. Clin Rheumatol 2022. [PMID: 35247132 DOI: 10.1007/s10067-022-06120-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
2 Santacruz JC, Londoño J, Santos AM, Arzuaga A, Mantilla MJ. Extra-Articular Manifestations in Reactive Arthritis due to COVID-19. Cureus 2021;13:e18620. [PMID: 34765373 DOI: 10.7759/cureus.18620] [Reference Citation Analysis]
3 Xu D, Zhang Y, Zhang ZY, Tang XM. Association between high mobility group box 1 protein and juvenile idiopathic arthritis: a prospective longitudinal study. Pediatr Rheumatol Online J 2021;19:112. [PMID: 34247641 DOI: 10.1186/s12969-021-00587-1] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Zeidler H, Hudson AP. Reactive Arthritis Update: Spotlight on New and Rare Infectious Agents Implicated as Pathogens. Curr Rheumatol Rep 2021;23:53. [PMID: 34196842 DOI: 10.1007/s11926-021-01018-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
5 Alexander SA, Kim E, Mandhadi R. Approaching Reactive Arthritis Associated With Poor Prognostic Factors: A Case Report and Literature Review. Cureus 2021;13:e13555. [PMID: 33815974 DOI: 10.7759/cureus.13555] [Reference Citation Analysis]
6 Bentaleb I, Abdelghani KB, Rostom S, Amine B, Laatar A, Bahiri R. Reactive Arthritis: Update. Curr Clin Microbiol Rep 2020;:1-9. [PMID: 33014690 DOI: 10.1007/s40588-020-00152-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
7 Wendling D, Prati C, Chouk M, Verhoeven F. Reactive Arthritis: Treatment Challenges and Future Perspectives. Curr Rheumatol Rep 2020;22. [DOI: 10.1007/s11926-020-00904-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
8 Thorsteinsson B, Geirsson AJ, Krogh NS, Gudbjornsson B. Outcomes and Safety of Tumor Necrosis Factor Inhibitors in Reactive Arthritis: A Nationwide Experience from Iceland. J Rheumatol 2020;47:1575-81. [DOI: 10.3899/jrheum.191307] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Byun SJ, Bae WH, Jung SM, Lee SW, Park YB, Song JJ. Fever as an initial manifestation of spondyloarthritis: A retrospective study. PLoS One 2017;12:e0184323. [PMID: 28910361 DOI: 10.1371/journal.pone.0184323] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
10 Misra R, Gupta L. Epidemiology: Time to revisit the concept of reactive arthritis. Nat Rev Rheumatol 2017;13:327-8. [PMID: 28490789 DOI: 10.1038/nrrheum.2017.69] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]